Human Xtensions Ltd

Human Xtensions Ltd (now operating as HumanTouch Surgical) is an Israeli public medical robotics company founded in January 2012 by Dr. Tamar Frenkel, Ziv Tamir and Mordechai Sholev. Originally named Human Extensions, the company changed its spelling to Human Xtensions in July 2017. It is headquartered in Israel and listed on the Tel Aviv Stock Exchange after raising ILS 158.7 million in its November 2020 IPO. The company develops and manufactures software-driven surgical devices designed to extend the reach and capabilities of the human hand. Its flagship product, the HandX® system, is a handheld surgical platform that combines the advantages of robotics with simplicity and cost-effectiveness, creating a new category in minimally invasive surgery. The system is designed to bridge the gap between conventional laparoscopy and large robotic systems, bringing robotic surgery benefits to any surgeon, in any setting, at scale. It consists of three main modules: a control module held by the surgeon, a drive module that translates hand movements into mechanical commands, and a detachable single-use end-effector module with articulated instruments such as needle holders and graspers. Human Xtensions received FDA clearance in March 2018 and CE mark approval in August 2018. In February 2021, it obtained FDA clearance for its disposable Monopolar Hook end-effector. Commercial marketing began in 2019 through Aesculap AG, the exclusive distributor in Europe, with additional distribution agreements in Israel, the Palestinian Authority, Egypt and Australia. The company is also developing a second-generation product called HandX-AI. Revenue declined sharply in the first half of 2021 to ILS 1.1 million from ILS 18.8 million in the same period of 2020, partly due to the COVID-19 pandemic's impact on distribution and healthcare budgets.

Human Xtensions Ltd was founded in January 2012 by Dr. Tamar Frenkel (who serves as CEO), Ziv Tamir and Mordechai Sholev. The company was initially named Human Extensions, and in July 2017 the spelling was changed to Human Xtensions. In November 2020, the company raised ILS 158.7 million in an IPO on the Tel Aviv Stock Exchange. The company develops and manufactures medical devices and is in the early stages of commercializing its products. It developed the HandX system, a surgeon-controlled operating room system for minimally invasive (laparoscopic) abdominal surgeries such as hernia repair, proctology and hysterectomy. The system comprises three main modules: a control module held by the surgeon to control the end effector; a drive module that translates hand movements into mechanical commands; and an end-effector module that connects to the drive unit and includes articulated instruments (such as a needle holder and grasper) inserted into the patient's body. End effectors are replaced after each procedure. The company states that its system offers a smart laparoscopy surgical solution combining the economic advantages of laparoscopic procedures with the technological advantages of robotic surgery for complex procedures. In March 2018, the company received FDA clearance, and in August 2018 it received CE mark approval. In February 2021, it received FDA clearance for its disposable Monopolar Hook end effector. The company is developing a second generation called HandX-AI. In 2019, the company began commercial marketing of its products through Aesculap AG, the exclusive distributor in Europe. The COVID-19 pandemic reduced distribution due to travel restrictions in Europe and redirection of healthcare budgets. The exclusive distributor in Israel and the Palestinian Authority is Tzemel Medical Ltd. The company also has distribution agreements in Egypt and Australia. In the first half of 2021, revenues dropped sharply to ILS 1.1 million, compared to ILS 18.8 million in the same period in 2020.

• 2021

  Received FDA clearance for disposable Monopolar Hook in February; revenues dropped to ILS 1.1 million in H1.

• 2020

  Raised ILS 158.7 million in IPO on Tel Aviv Stock Exchange in November.

• 2019

  Began commercial marketing through Aesculap AG in Europe.

• 2018

  Received FDA clearance in March and CE mark approval in August.

• 2017

  Name spelling changed to Human Xtensions in July.

• 2012

  Company founded in January by Dr. Tamar Frenkel, Ziv Tamir and Mordechai Sholev as Human Extensions.

Bridging the gap between laparoscopy and robotics with a handheld, cost-effective surgical platform.

• HandX® system

  Handheld surgical platform for minimally invasive abdominal surgery, bridging laparoscopy and robotics.

• Monopolar Hook

  Disposable end-effector that received FDA clearance in February 2021.

• HandX-AI

  Second-generation product under development.

1. 1Human Xtensions | Artefficient Surgeryhuman-x.com
2. 2Human Xtensions | Medical Robotics Company - a New Medical Realityhuman-x.com
3. 3Human Xtensions Ltd - Wikidatawikidata.org
4. 4יומן אקסטנשנס - Wikipedia (Hebrew)he.wikipedia.org